Navigation Links
SkinMedica Launches Redness Relief CalmPlex™
Date:2/3/2011

CARLSBAD, Calif., Feb. 3, 2011 /PRNewswire/ -- SkinMedica, Inc., the fastest-growing professional skin care company in the United States, today announced that it is introducing a new, fast-acting anti-redness product, Redness Relief CalmPlex™—the biggest innovation in redness in over two decades.  It is the first and only non-prescription product clinically proven to reduce visible redness.    

(Photo: http://photos.prnewswire.com/prnh/20110203/NY41924 )

(Logo: http://photos.prnewswire.com/prnh/20100810/NY48207LOGO)

This revolutionary formula contains, CalmPlex™, a patented, nature-inspired ingredient that treats the underlying causes of redness by inhibiting the release of a key natural vasodilator as well as niacinamide which helps to strengthen the skin by supporting the barrier function.  

"Visible redness is a real and emotional burden for millions of people," commented SkinMedica Founder, Richard Fitzpatrick, MD.  "As dermatologists, we have been frustrated by the lack of effective approaches to reducing the appearance of redness.  Backed by solid science and clinical results, Redness Relief CalmPlex™ represents a truly novel advance in the skin aesthetics area."

Ideal for sensitive skin types, this non-comedogenic formula contains no added fragrance and offers relief and results to improve overall skin appearance by neutralizing unwanted redness.

CLINICAL STUDIES:

In multiple clinical studies, Redness Relief CalmPlex™ demonstrated efficacy in relieving visible redness and improving overall skin tone. SkinMedica Redness Relief CalmPlex™ demonstrated a 40% reduction in UV-induced redness in as early as 3 days. Redness Relief CalmPlex™ also provided significant reductions in chronic redness after 1 week with continued improvement through week twelve.

Physicians assessing the clinical study reported the following results after only four weeks:

  • 43% reduction in appearance of visible redness
  • 51% improvement in evenness of skin tone
  • 49% improvement in overall severity

Participants in the study reported the following results at Week 4:

  • 78% of subjects reported an improvement in overall condition
  • 72% of subjects reported a reduction in visible redness
  • High patient satisfaction; 100% of subjects liked the product

SkinMedica Redness Relief CalmPlex™ launched the second week of January and is available through licensed physicians and medically supervised spas. Visit SkinMedica.com for locations.

About SkinMedica

SkinMedica, Inc. is focused on developing, acquiring and commercializing products that treat dermatologic conditions and improve the appearance of skin. The Company markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The Company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum™ and hallmark TNS Recovery Complex®. The formulations in the Company's clinical skin care collection enhance skin appearance, reduce signs of aging and provide other skin care benefits.

SkinMedica's prescription products include VANIQA® (eflornithine hydrochloride) Cream, 13.9%, the only FDA-approved prescription product for the reduction of unwanted facial hair in women and EpiQuin® Micro Cream (4% hydroquinone) for hyperpigmentation, or "brown spots" that commonly result from aging, inflammation or sun exposure.

SkinMedica is based in Carlsbad, California. For more information, visit: www.skinmedica.com.

TNS Recovery Complex®, VANIQA®, EpiQuin® Micro, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.


'/>"/>
SOURCE SkinMedica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Launches Senior Notes Offering
2. Merz Launches New Online Resource for Patients with Focal Dystonias
3. Thats Nice LLC Launches Nice Insight Marketing Intelligence for CRAMs With Its Pharma & Biotech Outsourcing Survey
4. REMCON Plastics Launches Aggressive 5 year Plan by Hiring New National Sales and Marketing Professional
5. Avantra Biosciences Launches Multiplex System for Faster, Easier Quantification of Cancer Protein Biomarkers
6. Global Coalition on Aging Launches as 450 Million People Turn 65 Over Next Two Decades
7. eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals
8. TheCarrot.com Launches Quit Smoking Program
9. Nonin Medical, Inc. Launches New WristOx2™, Model 3150 in U.S. and Canada
10. MMIS, Inc. Launches the MediSpend™ Aggregate Spend Solution
11. Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... YORK , Feb. 23, 2017  Genesis Healthcare ... Company. The announcement was made by Bill Monast ... David Hartley and Nathan Feltman , executives ... Genesis Healthcare Services, LLC. This acquisition ... largest provider of technology enabled durable medical equipment (DME) ...
(Date:2/23/2017)... Feb. 23, 2017 Nevro Corp. (NYSE: NVRO), a ... for the treatment of chronic pain, today reported financial results ... 2016. 2016 Accomplishment & Highlights: ... 2016, an increase of 228% as reported, over the prior ... an increase of 612% over the prior year ...
(Date:2/23/2017)... , Feb. 23, 2017 Research and Markets ... and Strategies - 2016" report to their offering. ... The latest research Fibromyalgia ... and benchmarks in the global Fibromyalgia market. The research ... key drugs marketed for Fibromyalgia and their clinical attributes? How are ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 23, 2017 , ... On April 13, 2017, The ... “Doping in Sport: How the Culture Might Change,” in conjunction with Pepperdine ... will be held at Pepperdine University in Malibu, California. , Sir Philip Craven, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, ... trials, today announced that Premier Research, a leading clinical development service provider, has ... are becoming increasingly complex, due in part to an array of circumstances including ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Center ... Rhode Island Consortium for Autism Research and Treatment (RI-CART) and Cinemaworld to present ... spectrum disorder (ASD) to see films in an environment that accommodates their unique ...
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal dentist ... today with a new Indiegogo campaign . Individuals are now able to contribute ... Los Angeles area, either as a participating patient or through an Indiegogo donation. The ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thomas Vas-Don suffered from ... regime, the author was able to successfully recover. In “ Origin & Insertion Charts ... various sources on the principals of massage, anatomy , trigger points and ...
Breaking Medicine News(10 mins):